India’s Mumbai Oncocare Centre (MOC) and Hemato Oncology Clinic-Vedanta (HOC) have announced the merger of their operations, creating a new entity known as MOC—HOC-Vedanta.

The latest strategic move is expected to broaden the scope of advanced cancer treatment availability across the Western Indian region, reported.

The merger has led to the establishment of a significant consortium of cancer specialists, combining the expertise and team of a total of 40 medical oncologists, as well as haematologists.

This integrated team is poised to care for over 22,000 cancer patients and administer upwards of 60,000 chemotherapy treatments yearly.

The report added that the services will be offered through a network of 22 community cancer care centres in Maharashtra, Madhya Pradesh, and Gujarat.  

MOC—HOC-Vedanta is not only enhancing the current healthcare landscape but also plans to extend its reach. The combined entity is looking to expand operations beyond its current geographical scope to deliver high-quality cancer care to patients throughout India.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

During the merger process, HOC-Vedanta received critical advisory and legal counsel from Caltius Ventures based in Ahmedabad and JSA.

In addition, Mumbai’s Affluence Advisors, as well as AZB, provided MOC with expert guidance and legal support, ensuring a smooth transition into the newly formed entity. quoted MOC medical oncologist promoter Dr Ashish Joshi as saying: “This merger is not just about adding beds; it’s about building a powerhouse for cancer care across Western India. We will be standardising care across all our centres, ensuring every patient receives the highest quality, evidence-based treatment available.”

An HOC-Vedanta representative said: “Imagine large-scale clinical trials, exploring groundbreaking new therapies and maximising the potential of existing ones. This collaboration will be a game-changer for cancer care in India and beyond.”